These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 25218883

  • 1. Successful management of severe intrahepatic cholestasis of pregnancy: report of a first Japanese case.
    Kamimura K, Abe H, Kamimura N, Yamaguchi M, Mamizu M, Ogi K, Takahashi Y, Mizuno K, Kamimura H, Kobayashi Y, Takeuchi M, Yoshida K, Yamada K, Enomoto T, Takakuwa K, Nomoto M, Obata M, Katsuragi Y, Mishima Y, Kominami R, Kamimura T, Aoyagi Y.
    BMC Gastroenterol; 2014 Sep 13; 14():160. PubMed ID: 25218883
    [Abstract] [Full Text] [Related]

  • 2. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A, Gervasi MT.
    Clin Liver Dis; 2016 Feb 13; 20(1):177-89. PubMed ID: 26593298
    [Abstract] [Full Text] [Related]

  • 3. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct 27; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May 27; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 9. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy.
    Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC.
    J Matern Fetal Med; 2001 Apr 27; 10(2):131-5. PubMed ID: 11392594
    [Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F, Zhang L, He MM, Liu ZF, Gao BX, Wang XD.
    Curr Med Res Opin; 2014 Aug 27; 30(8):1529-35. PubMed ID: 24665980
    [Abstract] [Full Text] [Related]

  • 11. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G, Fehér R, Gardó S, Fehér J.
    Orv Hetil; 2002 Dec 29; 143(52):2885-8. PubMed ID: 12638316
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 29; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 13. Clinical grading of intrahepatic cholestasis pregnancy.
    Pradhan M, Shao Y.
    JNMA J Nepal Med Assoc; 2013 Jan 29; 52(190):413-9. PubMed ID: 24362672
    [Abstract] [Full Text] [Related]

  • 14. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 15. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
    Yang J, Chen C, Liu M, Zhang S.
    Medicine (Baltimore); 2019 Jul 29; 98(27):e16214. PubMed ID: 31277130
    [Abstract] [Full Text] [Related]

  • 16. Fetal death in a patient with intrahepatic cholestasis of pregnancy.
    Sentilhes L, Verspyck E, Pia P, Marpeau L.
    Obstet Gynecol; 2006 Feb 29; 107(2 Pt 2):458-60. PubMed ID: 16449148
    [Abstract] [Full Text] [Related]

  • 17. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM.
    J Hepatol; 1998 Jan 29; 28(1):91-8. PubMed ID: 9537870
    [Abstract] [Full Text] [Related]

  • 18. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
    Berkane N, Cocheton JJ, Brehier D, Merviel P, Wolf C, Lefèvre G, Uzan S.
    Acta Obstet Gynecol Scand; 2000 Nov 29; 79(11):941-6. PubMed ID: 11081677
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
    Bacq Y, le Besco M, Lecuyer AI, Gendrot C, Potin J, Andres CR, Aubourg A.
    Dig Liver Dis; 2017 Jan 29; 49(1):63-69. PubMed ID: 27825922
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.